HODGKIN DISEASE RECURRENT

Clinical trials for HODGKIN DISEASE RECURRENT explained in plain language.

Never miss a new study

Get alerted when new HODGKIN DISEASE RECURRENT trials appear

Sign up with your email to follow new studies for HODGKIN DISEASE RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo aims to tame resistant blood cancers

Disease control Recruiting now

This study is testing if adding the drug ruxolitinib to the immunotherapy pembrolizumab is safe and can help control several types of lymphoma that have returned or resisted standard chemotherapy. It is for adults with specific T-cell or B-cell lymphomas who have tried at least o…

Matched conditions: HODGKIN DISEASE RECURRENT

Phase: PHASE2 • Sponsor: Seda S. Tolu • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

HODGKIN DISEASE RECURRENT

Get alerted when new HODGKIN DISEASE RECURRENT trials appear

New drug duo aims to tame resistant blood cancers